Mucormycosis is a rare, but emerging, life-threatening, rapidly progressive, angioinvasive fungal infection that usually occurs in immunocompromised patients. Pleuropulmonary mucormycosis is relatively rare disease and maintaining a high level of suspicion is important in right clinical setting with pleuropulmonary involvement that fails to respond to antibacterial agents because early recognition of this diagnosis, along with aggressive management, is critical to effective therapy and patient survival. We present a rare case  Pleuroparenchymal  Mucormycosis  with Diabetes.

1. C hayakulkeeree M et al: Zygomycosis: The re-emerging fungal infection. Eur J Clin Microbiol Infect Dis  2006;25:215.
2. Hamillos G, Samonis G, kontoyiannis DP. Pulmonary mucormycosis. Semin Respir Crit Care Med.2011; 32(6):693–702.
3. Lee FY, Mossad SB, Adal KA. Pulmonary mucormycosis: the last 30 years. Arch Intern Med. 1999;159(12):1301–1309.
4. Spellberg B, Kontoyiannis DP, Fredricks D, Morris MI, Perfect JR, Chin-Hong PV, et al. Risk factors for mortality in patients with mucormycosis. Med Mycol. 2012; 50(6):611–618.
5. Smith JA, Kauffman CA. Pulmonary fungal infections. Respirology. 2012; 17(6):913–926.
6. Wahidi MM, Rocha AT, Hollingsworth JW, Govert JA, Feller-Kopman D, Ernst A. Contraindications and safety of transbronchial lung biopsy via flexible bronchoscopy. A survey of pulmono-logists and review of the literature. Respiration. 2005; 72(3):285–295.
7. A lan M sagar : Mucormycosis. Harrisons Principles of Internal medicine 17th Edition 2008;1:1262.
8. Greenberg RN et al: Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006;50: 126.

Dr Prashant Yadav

Senior Resident, Department of Respiratory Medicine,

U P. University of Medical Sciences Saifai, Etawah, Uttar Pradesh- 206130 India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Phone 07408441516, 08400098260